Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-02-01, Stock:ABT, The news for the past five days is as follows:
2021-01-25: nan
2021-01-26: NEWS1: Earnings Preview: Abbott Laboratories.NEWS2: Abbott's Panbio Rapid Antigen Test Receives CE Mark for Asymptomatic Screening and Self-Administered Sample Collection with Nasal Swab.NEWS3: 2 Stocks I'll Hold Forever.
2021-01-27: NEWS1: Abbott Smashes Quarterly Estimates On Covid Testing Boom — Is ABT Stock A Buy?.NEWS2: Abbott Laboratories Stock Loses Buy Point Despite Coronavirus Test Boom.NEWS3: Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript.NEWS4: Here's How Abbott Labs Hit a Home Run With Its Q4 Results.NEWS5: Durable Goods Orders For December Rose Lower-than-Expected.NEWS6: Abbott (ABT) Q4 Earnings Top, Diagnostic Test Sales Solid.NEWS7: Abbott Stock Jumps As Coronavirus Tests Drive Quarterly Diagnostics Boom.NEWS8: P/E Ratio Insights for Abbott Laboratories.NEWS9: Abbott (ABT) Beats Q4 Earnings and Revenue Estimates.NEWS10: Abbott Laboratories: Q4 Earnings Insights.NEWS11: Abbott beats sales estimates as rapid diagnostics business now generates one-fourth of revenue.NEWS12: ABT Stock: Abbott Earnings Top, 2021 Guidance Strong.NEWS13: Abbott Reports Fourth-Quarter 2020 Results; Issues Strong Double-Digit Growth Forecast for 2021.NEWS14: What Does Abbott's Debt Look Like?.NEWS15: Abbott Laboratories Beats Earnings on Strong Sales.NEWS16: Abbott's Earnings Beat Gets Boost From Sales of Rapid Covid-19 Tests.
2021-01-28: NEWS1: Why Abbott Labs Stock Is Jumping Today.NEWS2: The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPO.NEWS3: Better Buy: Abbott Laboratories vs. Intuitive Surgical.
2021-01-29: NEWS1: Here's a Quick Technical Update on Abbott Laboratories.NEWS2: Abbott Laboratories (NYSE:ABT) Just Reported Yearly Earnings And Analysts Are Lifting Their Estimates.

Answer: Decrease